7-item ICD-11 screening scale by Bőthe et al. (2023). Assesses core CSBD symptoms: control, salience, relapse, dissatisfaction, and negative consequences.

Scoring Guide

Score range 7-28. ≥ 18 indicates high CSBD risk (sensitivity 82%, specificity 77%). Validated across 42 countries, α = .80.